# Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

> **NCT03384277** · PHASE4 · COMPLETED · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 66 (actual)

## Conditions studied

- Acquired Hemophilia A

## Interventions

- **DRUG:** Steroid
- **DRUG:** Rituximab
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT03384277
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-29
- **Primary completion:** 2022-06-09
- **Final completion:** 2022-07-09
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384277, "Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03384277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*